All data are based on the daily closing price as of December 6, 2024
h
Hyundai Bioscience
048410.KQ
10.05 USD
0.90
+9.84%
Overview
Last close
10.05 usd
Market cap
400.04M usd
52 week high
29.00 usd
52 week low
9.15 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
55.1192
Price/Book Value
11.7982
Enterprise Value
375.75M usd
EV/Revenue
33.7176
EV/EBITDA
-64.6317
Key financials
Revenue TTM
6.51M usd
Gross Profit TTM
2.39M usd
EBITDA TTM
-5.14M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
105.70B usd
Net debt
N/A usd
About
Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.